July 22nd, 2022
Two of our associates – LiMM Therapeutics and BSIM Therapeutics – were considered two of the most promising biotech companies in Portugal by Labiotech.eu
For more info: https://www.labiotech.eu/best-biotech/biotech-portugal-companies/
Sign up with your email address to receive news and updates.
By subscribing to receive news and updates you are automatically agreeing with our Terms & Conditions and Privacy Policy.
The launch of new drugs in the market has the solid purpose of fulfilling patient needs. Nowadays, the approval of new drug products depends on...
Our Mariana Branco just won the third prize of the AIDFM-CETERA Award for her article "Human multilineage pro-epicardium/foregut organoids support...
Last week Pedro Silva, President of the Direction, and Bárbara Gomes, AccelBio's CEO, were in Tel Aviv to get to know the Israeli innovation...